ArcScan is directed by a team of driven individuals dedicated to improving imaging, ultimately leading to superior diagnostics, surgical outcomes and patient care.
Executives and Company Officers
Dr. Dan Reinstein, MD – Chief Medical Officer
Dr. Dan Reinstein MD was appointed Chief Medical Officer in May 2015 but he has been acting as lead clinical consultant for many years. He is currently owner and Medical Director of the London Vision Clinic in the United Kingdom and also serves as Adjunct Professor of Ophthalmology at Columbia University Medical Center, New York, and Professeur Associé en Ophtalmologie at the Centre Hospitalier National d’Ophthalmologie des Quinzes Vingts, Paris.
Professor Reinstein MD received his undergraduate degree from Cambridge University and his postgraduate training in medicine at Cambridge University School of Medicine. He conducted his internship in medicine at the University College London School of Medicine, University of London. Dr. Reinstein MD. Then spent several years at the Weill Medical College of Cornell University in New York as a Bioengineering Fellow, developing very high-frequency (VHF) digital ultrasound technology (Artemis) for studying the micro-anatomical structure of the cornea in vivo.
Professor Reinstein’s research focuses on applications of the preliminary Insight® 100 technology to improve excimer corneal and phakic intraocular refractive surgery with a focus on measurement of the corneal epithelium for applications such as keratoconus screening and therapeutic corneal refractive surgery. His research has led to over 115 peer-reviewed publications, 30 book chapters and 500 international presentations and lectures. He was awarded the Waring Medal in 2006 and received the Kritzinger Award in 2013. Professor Reinstein holds over 10 patents in the field of laser eye surgery and ultrasound diagnostic imaging and signal processing.
Andrew K. Levien – CEO, Director
After joining ArcScan in 2010, Andy was appointed President and CEO of ArcScan in April 2012 where he is creating a practical structure to deliver transformational imaging applications. His career in industrial and mechanical device instrumentation, automation, and controls spans companies from startups to Fortune 100. With a focus on customer value creation, revenue growth, and operating profits, Andy brings technical and human management expertise to developing successful global organizations. He earned his master’s degree in engineering from the University of California, Berkeley, and has filled executive roles including serving as President and Global VP Operations of Norgren, SVP and General Manager roles at Emerson Electric Co. He was also the Executive Entrepreneur in Residence at Northwestern University in Evanston, Illinois, demonstrating his passion for bringing ideas to practical application through his keen technical, business and emotional intelligence.
Peter M. Ballachey, CPA-CA, CIA – Chief Financial Officer
Peter is meticulous, organized and strategic in his thinking and was formally appointed as ArcScan’s CFO in 2015. His expertise in finance and accounting is considerable with experience as Board Director, CFO and financial consultant . He also is an officer and co-founder of CRC Rail Management Services Ltd, as well as Director and Chief Financial Officer of Tractive Power Corporation. Peter served as Chief Financial Officer of Underground Energy Inc.
Peter is meticulous, organized, strategic in his thinking. His expertise in finance/accounting is considerable and ideally applicable for organizations such as ArcScan.
Barry Schafer – ArcScan Vice President of Sales and Marketing
Barry has demonstrated innovative business acumen with an advanced knowledge of Ophthalmic sales and management. He holds multiple medical patent holders, and has thrived in the field of Ophthalmology Sales for more than thirty years. He has contributed to the growth of many notable companies including: Johnson and Johnson, IOLAB, Bausch and Lomb, Eyeonics, Optimedica, Optos, Topcon and IBM. He joined ArcScan to steer the commercial launch of this unique ultrasound technology.
Barry understands how to build effective relationships that generate mutually favorable outcomes. Delving deeper than traditional sales, his ability to profile clients, identify, and meet their needs is a key scalable skill set with which he motivates and inspires his team. Treating each client as unique and valuable, he has developed long-term relationships that provide insight into growth opportunities in ophthalmology.
Erik Giphart – ArcScan Vice President of Engineering
Erik Giphart is an experienced CTO and R&D manager with 20+ years of progressive experience in scientific research, medical device design and development, as well as program and business management. He has a proven ability to provide vision, as well as strategic and technical leadership for innovation and research activities. Erik has a masters degree in Electrical Engineering from Delft University of Technology, Delft, the Netherlands, specializing in Information Theory (1994), and a PhD in Biomedical Engineering from Boston University (2001). He spent most of his academic career studying biomechanics, building advanced research environments such as a Virtual Reality Lab and a BioMotion Lab which included a 1000 fr/s stereo x-ray imaging system, publishing 30+ peer reviewed articles in both well-known engineering and clinical journals along the way. After a working at Boston University and at the Steadman Philippon Research Institute in Vail, Colorado, in research capacities, he switched to the medical device industry in 2012.
Erik joined Halifax Biomedical Inc (HBI) in Canada, a start-up company commercializing stereo x-ray technology, serving as Director of Engineering and CTO shortly. He directed two major programs involving the development of surgical instrumentation, static and dynamic stereo x-ray equipment, advanced 3D image analysis software, a tele-radiology framework for image analysis, and a mobile imaging trailer. Upon his return to Colorado, Erik joined Evergreen Research Inc, as Director of Engineering which introduced him to ArcScan. As VP of Engineering, he is responsible for developing the Engineering function within ArcScan and bringing all R&D activities in-house.
Morris Bellows – Director of RAQA, Quality
Morris has extensive background in quality, processes, and regulatory compliance. In his year at ArcScan he has established documentation to support standardizing manufacturing, service, and other important aspects of production. His past roles for global organizations have fine-tuned his ability to identify compliance needs that he then implements into the daily activities of the organization.
In addition to the critical process of documentation, he nimbly addresses varying needs for device sales around the world, adding strategic insight to his detailed ability to ensure the organization meets the requirements of each market. He is a true partner with his colleagues, understanding that a work flow that fits the tools and resources of the organization is the best way to ensure that the staff understands their roles and responsibilities.
Karen Lundquist – Director of Marketing and Communication
Karen has been intimately involved in successful B2B medical devices and pharma for more than two decades. From strategy to implementation, global product launches and effective branding, her portfolio demonstrates how impactful marketing springs from research and understanding of the healthcare landscape. In the age of digital marketing, she thrives by utilizing analytics to identify what channels and messaging work most efficiently.
She earned her MBC at St. Thomas University, complete with a capstone original research project, and has presented at multiple conferences. She is proud of her partnership-building throughout verticals, including volunteering to offer education and participating in advocacy that ensures access to care for amputees, including veterans and children.
Staff
George Heath
Manager of Field Services
Christine Stone
Clinical Applications Manager
Tricia Hewitt Huckabee
Human Resources Manager
David Spence
National Director
Davis Benz, PE
Sr. Mechatronics Engineer
Sam Boytor
Sr. Manufacturing Engineer
Clayton Braden
Field Service Engineer
Dorian Brown
Electrical Design Engineer
Sam Brown
Mechanical Design Engineer
Heather Duffy
Controller
Andrew Gillespie
Field Service Engineer
Tyler Jordan
Mechanical Design Engineer
Sam Keo
Field Service Engineer
Tori King
Quality Engineer
Sandesh Kulkarni
Intern
Will Sanders
Quality Engineer
Matt Sassu
Sr. Software Engineer
Naya Ziegler
Quality Engineer
Board of Directors
Andrew K. Levien – CEO, Director
After joining ArcScan in 2010, Andy was appointed President and CEO of ArcScan in April 2012 where he is creating a practical structure to deliver transformational imaging applications. His career in industrial and mechanical device instrumentation, automation, and controls spans companies from startups to Fortune 100. With a focus on customer value creation, revenue growth, and operating profits, Andy brings technical and human management expertise to developing successful global organizations. He earned his master’s degree in engineering from the University of California, Berkeley, and has filled executive roles including serving as President and Global VP Operations of Norgren, SVP and General Manager roles at Emerson Electric Co. He was also the Executive Entrepreneur in Residence at Northwestern University in Evanston, Illinois, demonstrating his passion for bringing ideas to practical application through his keen technical, business and emotional intelligence.
Loren Brown – Director
Loren Brown is president of Vance Brown and Associates, a San Francisco Bay area firm established in 1932. Brown is a third generation relative of the founder, Vance Meacham Brown. The company has extensive experience in a variety of construction improvements for a multitude of owners, architects, and tenants in many different municipalities. The firm has constructed many projects at Stanford University, as well as private school buildings, biotech laboratories, clean rooms, senior housing projects, restaurants, and warehouses. Notable projects include the Stanford tennis and football stadiums, Quantum Corporate Headquarters, The Hamilton, Evvia Restaurant, Tully’s Coffee, ALZA Corporate Headquarters, Westport Office Park, as well as Stanford University’s Arillaga Family Sports Center, Alumni Center, and Boathouse.
Ramgopal (RAM) P. Rao – Director
Ram is a serial entrepreneur with 25 years of experience in the ophthalmic pharmaceutical and device industry. Ramgopal is inventor, founder and chief executive officer of LensGen, Inc., a clinical stage medical device company that is developing a novel intraocular lens for presbyopia. The Company has received support from one of the largest medical device companies in the world. LensGen closed a $28.0 million Series A Financing in May 2018.
Currently he is also Chairman of the Board of 2C Tech Corporation, Inc., an emerging medical device company that is developing a novel nanotechnology application for preservation of vision for patients with degenerative retinal diseases. 2C Tech Completed Series B Financing in 2016 and 2019.
Ram co-developed an innovative corneal implant device for presbyopia and licensed the technology to (venture funded) Acufocus, Inc. The company is now commercializing the product on a global scale. Prior to that, Ram founded Tomey Technology Inc., that pioneered the corneal topography imaging technology that is now a standard of care in eye care for LASIK and cataract surgery. This joint venture company was acquired by Tomey Corporation of Japan. He was Chief Operating Officer and Director of Vitreoretinal Technologies, Inc., a venture funded ophthalmic pharmaceutical company that developed a drug for diabetic retinopathy. Ram was President of Ophthalmic Group at Premier Laser Systems, Inc.; a publicly held company that developed the first laser assisted cataract surgery technology. He also held various executive positions at Biorad Laboratories, Inc.
Luca M. Sergio – Director
Luca is the CEO of Ethis Communications, a marketing communications agency focused on ophthalmology and optometry and Managing Partner of Ethis HealthTech, a consultancy addressing strategy and business development. Chief catalyst behind Topcon’s EyeRoute Synergy platform in eyecare. Luca gravitates towards multicultural corporate environments, from German, to Japanese, to Italian and American. He is fluent in Italian, has a reading knowledge of Spanish, and is a native English speaker.
Luca has used his expertise to reposition and transform med-tech companies, via re-imagining corporate vision, devising strategic and execution plan, identifying resource requirements for success, catalyzing new product development, and ensuring departmental alignment by injecting energy and fostering cohesion amongst the team.
Roger Sun, MD, MBA – Director
Roger Sun has over 25 years of experience in business development, venture development and investment, corporate strategy and planning, alliance/partnership management, portfolio management, new product development, marketing strategy and clinical practice from various roles in biotechnology industry. Dr. Sun is the CEO and founder of Simedice Biotechnologies, Inc. which develops, manufactures, and markets high-end hydrophobic intraocular lens products including trifocal lens, trifocal toric lens and EDOF lens to treat global cataract patients.
Prior to Simedice, Dr. Sun was an investment director of Baxter Ventures in Baxter Healthcare Corporation to directly work with innovative biotechnology startups from concepts to marketed better medical products and eventual company IPOs. Prior to Baxter, Dr. Sun worked in the business development group of Bayer Healthcare Corporation to establish and manage business partnerships such as technology in-licensing and company acquisitions. Dr. Sun received his MD in ophthalmology from Peking University Medical Science Center and his MBA in finance and entrepreneurship from Kelly School of Business in Indiana University at Bloomington. Dr. Sun has published more than 20 scientific papers in peer-reviewed international scientific journals.